Multiple sclerosis: pharmacogenomics and personalised drug treatment

被引：0
|
作者：
V. Annibali
G. Ristori
S. Cannoni
S. Romano
A. Visconti
A. Ghazaryan
L. Figà Talamanca
M. Salvetti
R. Mechelli
机构：
[1] Ospedale S. Andrea,Department of Neurology and Centro Neurologico Terapia Sperimentale (CENTERS)
[2] University of Rome “La Sapienza”,undefined
来源：
Neurological Sciences | 2006年 / 27卷
关键词：
Pharmacogenomics; Multiple sclerosis; Therapy; Microarrays;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Multiple sclerosis (MS) is a disorder of the central nervous system with an inflammatory and a neurodegenerative component. We do not yet have a definitive therapy for MS. Attempts to develop new treatments are long and costly and should be paralleled by studies aimed at increasing the therapeutic index of the existing treatments, interferon β and glatiramer acetate. Pharmacogenetics and pharmacogenomics may be of use in this respect though their application may not be straightforward, particularly in MS.
引用
收藏
页码：s347 / s349
相关论文
共 50 条
  • [1] Multiple sclerosis: pharmacogenomics and personalised drug treatment
    Annibali, V.
    Ristori, G.
    Cannoni, S.
    Romano, S.
    Visconti, A.
    Ghazaryan, A.
    Talamanca, L. Figa
    Salvetti, M.
    Mechelli, R.
    NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 5) : S347 - S349
  • [2] Pharmacogenomics of multiple sclerosis
    Favorova, O.
    Kulakova, O.
    Tsareva, E.
    Lvovs, D.
    Favorov, A.
    Vandenbroeck, K.
    Boyko, A.
    FEBS JOURNAL, 2013, 280 : 343 - 343
  • [3] Drug treatment of multiple sclerosis
    Polman, CH
    Uitdehaag, BMJ
    WESTERN JOURNAL OF MEDICINE, 2000, 173 (06): : 398 - 402
  • [4] Pharmacogenomics and personalised analgesia
    Lambert, David
    TRENDS IN ANAESTHESIA AND CRITICAL CARE, 2011, 1 (03) : 115 - 116
  • [5] The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis
    Kowalec, Kaarina
    Carleton, Bruce
    Tremlett, Helen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (03) : 183 - 192
  • [6] Pharmacogenomics of Multiple Sclerosis: A Systematic Review
    Hocevar, Keli
    Ristic, Smiljana
    Peterlin, Borut
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [7] Current Developments in Pharmacogenomics of Multiple Sclerosis
    Rebecca J. Carlson
    J. Ronald Doucette
    Adil J. Nazarali
    Cellular and Molecular Neurobiology, 2014, 34 : 1081 - 1085
  • [8] IFN-β pharmacogenomics in multiple sclerosis
    Vandenbroeck, Koen
    Urcelay, Elena
    Comabella, Manuel
    PHARMACOGENOMICS, 2010, 11 (08) : 1137 - 1148
  • [9] Personalised medicine for multiple sclerosis care
    Gafson, Arie
    Craner, Matt J.
    Matthews, Paul M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (03) : 362 - 369
  • [10] Current Developments in Pharmacogenomics of Multiple Sclerosis
    Carlson, Rebecca J.
    Doucette, J. Ronald
    Nazarali, Adil J.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2014, 34 (08) : 1081 - 1085
12345